Patterns of disease spread varied significantly among patients with clear cell, papillary, and chromophobe renal cell carcinoma and may reflect differences in disease biology, according to investigators.
Chemotherapy agents such as vincristine sulfate injection, vinblastine sulfate injection, and vinorelbine tartrate injection should only be prepared in IV infusion bags.
A meta-analysis suggests that abiraterone or apalutamide added to androgen deprivation therapy for men with metastatic castration-sensitive prostate cancer offers the best overall survival.
Nubeqa, an androgen receptor inhibitor, was approved for the treatment of patients with nmCRPC based on data from the placebo-controlled phase 3 ARAMIS trial.
With the advent of more reliable and accurate ways to screen for prostate cancer, such as PSA testing and prostate MRI, the authors argue that it is time to stop the “antiquated practice” of the digital rectal examination.
